click click click
58587
Signals
https://www.painnewsnetwork.org/stories/2023/5/17/medical-cannabis-linked-to-significant-improvements-in-physical-and-mental-health
By Pat Anson, PNN EditorThe use of medical cannabis was associated with "significant improvements" in physical and mental health in a large survey of Australian adults suffering from chronic pain and other health problems. Over 3,100 people participated in the survey. Chronic non-cancer pain was...
58588
Signals
https://www.cbc.ca/radio/unreserved/indigenous-talent-in-the-music-industry-is-creating-a-beautiful-resistance-1.6846045?cmp=rss
Unreserved51:485 rising musicians share their songs and successThe music industry is bursting with Indigenous talent spanning across genres and telling their own stories in their own ways. "The coolest music ...with the best lyrics and message is coming from our communities because we actually...
58698
Signals
https://www.pharmaceutical-technology.com/news/inflation-reduction-act-panel/
The Inflation Reduction Act, which became US law in August 2022, has invited its fair share of critics and supporters over its drug pricing provisions. At a lively panel at Financial Times US Pharma and Biotech Summit on May 16, panellists were at odds over whether the new legislation would...
58989
Signals
https://www.appeal-democrat.com/opinion/other-view-america-s-health-care-system-benefits-the-insurance-industry-not-patients-or-doctors/article_86b422d8-f508-11ed-b6e3-23f772652ab4.html
Could this be the year when America starts to shift away from the employer-sponsored health insurance model?To be sure, health care is an issue that concerns most people. Whether it is accessing care or paying for health care services, few people are free of the anxiety that comes when they or a...
59179
Signals
https://www.pharmaceutical-technology.com/news/kamada-glassia-marketing-swissmedic/
Biopharmaceutical company Kamada has received marketing authorisation from Swissmedic for human alpha1-proteinase inhibitor Glassia to treat Alpha-1 antitrypsin deficiency (AATD) in Switzerland.
Glassia is indicated for chronic augmentation and as a maintenance therapy for people with clinically...
Glassia is indicated for chronic augmentation and as a maintenance therapy for people with clinically...
